All News

Urologists are expected to spend more money on building a solid infrastructure and expanding technology at a time when many are concerned about practice economics. Fortunately, there are some actions you can take to improve practice finances.

Submit a question for an upcoming Urology Times Q&A.

Newer, more expensive treatment options for prostate cancer were adopted rapidly and widely during 2002 through 2005 without proof of their cost-effectiveness, according to a recent study.

Updated National Comprehensive Cancer Network guidelines call for more rigorous monitoring of men with prostate cancer undergoing active surveillance and include new treatment options for patients with advanced disease.

The Medicare Payment Advisory Commission (MedPAC) has recommended a 1% increase in payments for physician services in 2012 as part of its "Report to the Congress: Medicare Payment Policy."

The AUA, the American Association of Clinical Urologists, and seven other specialty societies have joined forces to support legislation introduced in the Maryland General Assembly to amend the state?s current self-referral law, which the AUA says threatens to seriously restrict patient access to imaging and radiation therapy services.

In a recent letter to the FDA, the American Medical Association called for genetic testing to be conducted under the guidance of a physician, genetic counselor, or other genetics specialist.

High rates of inappropriate antibiotic use persist despite a 15-year national outreach campaign by the Centers for Disease Control and Prevention to educate providers and consumers on the dangers of antibiotic overuse, according to an issue brief from the Center for Healthcare Research & Transformation, Ann Arbor, MI.

When hospitals acquire surgical robotic technology, men in that region are more likely to undergo radical prostatectomy, according to a recent multicenter study.

Microdissection testicular sperm extraction (TESE) can effectively locate and extract viable sperm in more than one-third of adult male childhood cancer survivors who were previously considered sterile due to prior chemotherapy treatment, according to a recent study.

Researchers at the Institute for Regenerative Medicine have used patients? own cells to build tailor-made urethras and successfully replace damaged tissue.

Researchers at the University of Michigan Comprehensive Cancer Center, Ann Arbor, have identified a potential target to treat an aggressive type of prostate cancer.

Men who take nonsteroidal anti-inflammatory drugs three times per day for more than 3 months are 2.4 times more likely to have erectile dysfunction than men who do not take the drugs regularly, say researchers from several California locations of Kaiser Permanente.

More than 21,000 health care providers initiated registration for the Medicare and Medicaid EHR Incentive Programs in January, and four states reported initial Medicaid incentive payments totaling more than $20 million, the Centers for Medicare & Medicaid Services reported.

PSA velocity is a poor predictor of prostate cancer and may lead to many unnecessary biopsies, according to a recent study.

The RANK Ligand inhibitor denosumab (Xgeva) significantly delays skeletal-related events (SREs) in men with prostate cancer and bone metastases, French researchers recently reported.

A genetic pattern may predict how aggressive prostate cancer is before treatment and whether the disease will recur in men who have already been treated, according to research from Queen Mary, University of London.

The AUA has released its first clinical guideline on the diagnosis and treatment of interstitial cystitis/bladder pain syndrome (IC/BPS).

A new health education campaign is harnessing the power of sports and celebrities to bring prostate cancer to the forefront as a critical men's health issue and to challenge men to take charge of their health.

The FDA has cleared a test to help manage potential organ rejection in kidney transplant patients.

External beam radiation therapy (EBRT) remains the mainstay for treating bone metastases, according to a new American Society for Radiation Oncology guideline for the use of radiation therapy in treating bone metastases.

In a collaborative project involving scientists from three continents, researchers have identified a gene that is mutated in one in three patients with the most common form of renal cancer.

A new blood test can detect the abnormal pattern of chemical alteration of DNA associated with bladder cancer, suggesting it may be possible to assess susceptibility to the disease, say researchers from Brown University, Providence, RI.

Nerve-sparing radical prostatectomy is likely to help preserve erectile function regardless of the route of operation; however, nerve sparing appears to have no impact on the prevalence of postoperative incontinence.

This list of U.S.-based National Institutes of Health trials is derived from the NIH's database and includes U.S. phase II, III, and IV overactive bladder trials that are currently recruiting participants as well as phase II BPH trials. This list is current as of Feb. 16, 2011.

Urology drugs and devices that are in the pipeline from Exelixis, Inc., ADVENTRX Pharmaceuticals, Viking Systems, Inc., Epigenomics AG, and Predictive Biosciences.

The Reid Tax Relief, Unemployment Insurance Reauthorization, and Job Creation Act of 2010 will likely affect your 2010 taxes.